Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees | 158 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has completed its previously announced shares... ► Artikel lesen | |
08.01. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 430,930 shares as interest payment | 4 | Stockwatch | ||
07.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 347 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
24.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose to issue shares for director fees | 3 | Stockwatch | ||
RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
24.12.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 342 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
11.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose arranges $6-million private placement | 8 | Stockwatch | ||
10.12.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement | 402 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 10, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement... ► Artikel lesen | |
06.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose applies for patent on Lidocaine film strip | 1 | Stockwatch | ||
05.12.24 | Rapid Dose Therapeutics Corp. Files Patent Application for Lidocaine Oral Thin Strip | 263 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 5, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is pleased to announce that it has filed... ► Artikel lesen | |
30.10.24 | Rapid Dose Therapeutics Corp: Rapid Dose closes final tranche of financing | 1 | Stockwatch | ||
30.10.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement | 363 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a second and final tranche of... ► Artikel lesen | |
02.10.24 | Rapid Dose Therapeutics Corp: Rapid Dose to issue 557,677 shares for debt | 3 | Stockwatch | ||
02.10.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Interest on Secured Debt | 525 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
17.09.24 | Rapid Dose Therapeutics Corp: Rapid Dose extends private placement to Oct. 29 | 4 | Stockwatch | ||
17.09.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Common Share Private Placement | 472 | Newsfile | Burlington, Ontario--(Newsfile Corp. - September 16, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated August 7, 2024... ► Artikel lesen | |
22.07.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of First Tranche of Common Share Private Placement | 263 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a first tranche of its previously... ► Artikel lesen | |
03.07.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Announces Payment in Shares for Interest on Secured Debt | 520 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
02.07.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Reports Fiscal Year 2024 Financial Results | 260 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), is pleased to announce the filing of its financial results for the year ended... ► Artikel lesen | |
25.06.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant | 216 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE is pleased to... ► Artikel lesen | |
19.06.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Common Share Private Placement | 298 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 8, 2024, regarding... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 114,80 | +1,95 % | Kaufempfehlung bekräftigt: BioNTech: Spannende Pipeline macht Hoffnung auf deutlichen Kursanstieg | © Foto: Julia Cebella - dpaDie Analysten von Berenberg Research sehen großes Potenzial in BioNTechs Onkologie-Pipeline und betonen, dass die bevorstehenden klinischen Auswertungen bis 2025 die Bewertung... ► Artikel lesen | |
CORE ONE LABS | 0,079 | -100,00 % | Prusa gibt Update zum 3D-Drucker CORE One: Erste Auslieferungen stehen bevor | ||
CLINUVEL | 7,010 | -2,10 % | Clinuvel Pharmaceuticals Aktie: So sehen Experten die Lage | Nach den jüngsten Entwicklungen verzeichnet die Clinuvel Pharmaceuticals Aktie weiterhin eine rückläufige Tendenz. Am 17. Januar 2025 fiel der Kurs um 0,77 Prozent auf 7,10 EUR, was die anhaltende Schwächephase... ► Artikel lesen | |
BIONXT SOLUTIONS | 0,272 | +1,12 % | Bayer wachgeküsst! BioNxt Solutions, Novo Nordisk - jetzt in die Gewinner von morgen investieren | Die Wirtschaft befindet sich im Wandel, denn mit der rasanten Entwicklung im Bereich Künstliche Intelligenz können technologische Innovationen entwickelt werden, die neue Maßstäbe setzen könnten. Diese... ► Artikel lesen | |
AMYRIS | - | - | BioMaP-Consortium Contracts Amyris to Support Domestic Medicines Supply | ||
ATAI LIFE SCIENCES | 1,450 | -3,40 % | ATAI Life Sciences N.V. - 8-K, Current Report | ||
VIDAC PHARMA | 0,650 | +16,07 % | Vidac Pharma Holding kündigt die Teilnahme von Dr. Max Herzberg am innovativen Hirntumortreffen auf dem Google Campus in Tel Aviv | London (UK), 23. Januar 2025 - Vidac Pharma Holdings Plc. (Hamburg und Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), ist ein biopharmazeutisches Unternehmen
in der klinischen Phase der Onkologie... ► Artikel lesen | |
SOL GLOBAL INVESTMENTS | 0,280 | -5,41 % | MEME-Coin Hype!: Kursexplosion und frische Allzeit-Hochs bei Solana! Mit dieser Aktie profitieren Sie sofort! | ||
MUSTGROW BIOLOGICS | 0,962 | +1,05 % | MustGrow Biologics Corp.: MustGrow Announces Closing of Private Placement of Units for $2,585,000 | Saskatoon, Saskatchewan--(Newsfile Corp. - January 16, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the closing of the... ► Artikel lesen | |
ENTHEON BIOMEDICAL CORP | 0,256 | 0,00 % | Entheon Biomedical Corp.: Entheon Announces Agreement to Acquire Mentis AI | Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered... ► Artikel lesen | |
CARA THERAPEUTICS | 5,750 | -2,21 % | Cara Therapeutics, Inc. - S-4/A, Registration of securities, business combinations | ||
REVIVE THERAPEUTICS | 0,005 | -33,33 % | Revive Therapeutics Ltd.: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure | TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
CYBIN | 9,300 | -2,62 % | Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results | TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare... ► Artikel lesen | |
ARTELO BIOSCIENCES | 1,180 | 0,00 % | Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12 | The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjects Initial safety and pharmacokinetic data expected during the first half 2025 SOLANA BEACH, Calif., Jan.... ► Artikel lesen | |
AWAKN LIFE SCIENCES | 0,074 | -100,00 % | Awakn Life Sciences Corp.: Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD | Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company focused... ► Artikel lesen |